JP2018538253A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018538253A5 JP2018538253A5 JP2018522572A JP2018522572A JP2018538253A5 JP 2018538253 A5 JP2018538253 A5 JP 2018538253A5 JP 2018522572 A JP2018522572 A JP 2018522572A JP 2018522572 A JP2018522572 A JP 2018522572A JP 2018538253 A5 JP2018538253 A5 JP 2018538253A5
- Authority
- JP
- Japan
- Prior art keywords
- dimethyl
- methylpyrimidin
- indoline
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)(c(c(N1*(*)N*)c2)ccc2-c2cnc(C)nc2)C1=O Chemical compound CC(C)(c(c(N1*(*)N*)c2)ccc2-c2cnc(C)nc2)C1=O 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15193355 | 2015-11-06 | ||
| EP15193355.3 | 2015-11-06 | ||
| PCT/EP2016/076315 WO2017076842A1 (en) | 2015-11-06 | 2016-11-02 | Indolin-2-one derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018538253A JP2018538253A (ja) | 2018-12-27 |
| JP2018538253A5 true JP2018538253A5 (enExample) | 2019-11-28 |
| JP6839184B2 JP6839184B2 (ja) | 2021-03-03 |
Family
ID=54476823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522572A Active JP6839184B2 (ja) | 2015-11-06 | 2016-11-02 | インドリン−２−オン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10519140B2 (enExample) |
| EP (1) | EP3371174B1 (enExample) |
| JP (1) | JP6839184B2 (enExample) |
| CN (1) | CN108137561B (enExample) |
| AR (1) | AR106589A1 (enExample) |
| TW (1) | TWI614244B (enExample) |
| WO (1) | WO2017076842A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE050083T2 (hu) | 2015-11-06 | 2020-11-30 | Hoffmann La Roche | Indolin-2-on származékok |
| JP6857653B2 (ja) | 2015-11-06 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｃｎｓ及び関連障害の治療において使用するためのインドリン−２−オン誘導体 |
| EP3371174B1 (en) | 2015-11-06 | 2021-03-17 | H. Hoffnabb-La Roche Ag | Indolin-2-one derivatives |
| JP6857651B2 (ja) | 2015-11-06 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｃｎｓ疾患の処置に有用なインドリン−２−オン誘導体 |
| US20210393621A1 (en) | 2018-10-26 | 2021-12-23 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
| JP2022550463A (ja) | 2019-10-01 | 2022-12-01 | エンピリアン ニューロサイエンス， インコーポレイテッド | トリプタミン発現を調整する真菌の遺伝子操作 |
| WO2021231933A1 (en) * | 2020-05-15 | 2021-11-18 | Neucyte Pharmaceuticals | Anti-epileptic pharmaceutical compositions and use thereof |
| WO2023130075A2 (en) | 2021-12-31 | 2023-07-06 | Empyrean Neuroscience, Inc. | Genetically modified organisms for producing psychotropic alkaloids |
| CN122122140A (zh) * | 2024-09-27 | 2026-05-29 | 成都麻沸散医药科技有限公司 | 一种化合物及其制备方法和用途 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3935514A1 (de) | 1989-10-25 | 1991-05-02 | Boehringer Mannheim Gmbh | Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| TW251284B (enExample) | 1992-11-02 | 1995-07-11 | Pfizer | |
| DE4427648A1 (de) | 1994-08-04 | 1996-02-08 | Basf Ag | N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung |
| FR2757157B1 (fr) | 1996-12-13 | 1999-12-31 | Sanofi Sa | Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant |
| WO2000040581A1 (en) | 1999-01-07 | 2000-07-13 | American Home Products Corporation | 3,4-dihydro-2h-benzo[1,4]oxazine derivatives |
| EP1303269B1 (en) | 2000-06-29 | 2005-12-07 | NeuroSearch A/S | Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| WO2004060902A2 (en) | 2002-12-31 | 2004-07-22 | John K Buolamwini | Novel nucleoside transport inhibitors |
| SK51052006A3 (sk) | 2004-05-11 | 2007-05-03 | Egis Gy�gyszergy�r Nyrt. | Pyridínové deriváty alkyloxindolov ako aktívne látky voči 5-HT7 receptoru |
| US20060253263A1 (en) | 2005-04-11 | 2006-11-09 | Meshkin Brian J | Method to optimize drug selection, dosing and evaluation and to help predict therapeutic response and toxicity from immunosuppressant therapy |
| AR056317A1 (es) | 2005-04-20 | 2007-10-03 | Xenon Pharmaceuticals Inc | Compuestos de oxindol y composicion farmaceutica |
| AR053713A1 (es) | 2005-04-20 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos heterociclicos y sus usos como agentes terapeuticos |
| MX2008016083A (es) | 2006-06-26 | 2009-03-20 | Helicon Therapeutics Inc | Metodo para modular la excrecion de neuritas por el uso de un antagonista del receptor de galanina-3. |
| WO2008046083A2 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Use of oxindole compounds as therapeutic agents |
| EP2114921B1 (en) | 2006-12-30 | 2012-12-26 | Abbott GmbH & Co. KG | Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| UY30846A1 (es) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos |
| JO3126B1 (ar) * | 2007-11-14 | 2017-09-20 | Janssen Pharmaceutica Nv | مثبطات ناقل نيوكليوسيد متوازن اي ان تي 1 |
| EP2108641A1 (en) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| EP2113503A1 (en) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors |
| JO3265B1 (ar) | 2008-12-09 | 2018-09-16 | Novartis Ag | مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض |
| ES2590531T3 (es) | 2012-09-13 | 2016-11-22 | F. Hoffmann-La Roche Ag | 2-oxo-2,3-dihidro-indoles para el tratamiento de trastornos del SNC |
| KR101811549B1 (ko) * | 2013-06-19 | 2017-12-26 | 에프. 호프만-라 로슈 아게 | 인돌린-2-온 또는 피롤로-피리딘/피리미딘-2-온 유도체 |
| FR3017867A1 (fr) * | 2014-02-21 | 2015-08-28 | Inventiva | Nouveaux composes de type phenylazetidine carboxylate ou carboxamide |
| PE20161476A1 (es) * | 2014-06-26 | 2017-01-07 | Hoffmann La Roche | Derivados de indolin-2-ona o pirrolo-piridin-2-ona |
| EP3371174B1 (en) | 2015-11-06 | 2021-03-17 | H. Hoffnabb-La Roche Ag | Indolin-2-one derivatives |
| JP6857651B2 (ja) | 2015-11-06 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｃｎｓ疾患の処置に有用なインドリン−２−オン誘導体 |
| JP6857653B2 (ja) | 2015-11-06 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｃｎｓ及び関連障害の治療において使用するためのインドリン−２−オン誘導体 |
| HUE050083T2 (hu) | 2015-11-06 | 2020-11-30 | Hoffmann La Roche | Indolin-2-on származékok |
-
2016
- 2016-11-02 EP EP16790588.4A patent/EP3371174B1/en active Active
- 2016-11-02 JP JP2018522572A patent/JP6839184B2/ja active Active
- 2016-11-02 CN CN201680056575.2A patent/CN108137561B/zh active Active
- 2016-11-02 WO PCT/EP2016/076315 patent/WO2017076842A1/en not_active Ceased
- 2016-11-04 AR ARP160103364A patent/AR106589A1/es unknown
- 2016-11-04 TW TW105135829A patent/TWI614244B/zh not_active IP Right Cessation
-
2018
- 2018-05-04 US US15/971,368 patent/US10519140B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6776399B2 (ja) | ＰＩ３Ｋδ関連障害治療のためのピラゾロピリミジン誘導体の使用 | |
| JP6067709B2 (ja) | Ｐｉ３ｋ阻害剤としてのヘテロシクリルアミン | |
| JP5823518B2 (ja) | ブルトン型チロシンキナーゼの阻害剤 | |
| AU2009260726B2 (en) | S1P1 receptor agonists and use thereof | |
| CN103917528B (zh) | 嘧啶pde10抑制剂 | |
| JP6649540B2 (ja) | 置換されたヘテロアリール化合物および使用方法 | |
| US11739095B2 (en) | Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulators | |
| RU2015152576A (ru) | Производные индолин-2-она или пирролопиридин/пиримидин-2-она | |
| KR20120035158A (ko) | 1,２,４?트리아졸로［４,３?ａ］피리딘 유도체 및 ｍＧｌｕＲ２ 수용체의 양성 알로스테릭 조절자로서의 그의 용도 | |
| JP2018527384A (ja) | がんの治療のためのｂｔｋ阻害剤としてのピラゾロピリミジン誘導体 | |
| ME01488B (me) | Derivati oksadiazola i njihovo korišćenje kao potencijatora metabotropnih glutamatnih receptora-842 | |
| CN105732639A (zh) | 作为LRRK2抑制剂的4-(取代的氨基)-7H-吡咯并〔2,3-d〕嘧啶类 | |
| JP2013539762A (ja) | フロ［３，２−ｄ］ピリミジン化合物 | |
| CN106432246B (zh) | 杂芳化合物及其在药物中的应用 | |
| CN1926140A (zh) | 吡咯并嘧啶衍生物 | |
| RU2018120703A (ru) | Производные индолин-2-она | |
| TW201446767A (zh) | 作為磷脂肌醇3-激酶抑製劑之吡咯並三嗪衍生物 | |
| JP2019537581A5 (enExample) | ||
| TW201422627A (zh) | 吡咯三嗪酮衍生物之化合物、醫藥組成物、用途及組合產品 | |
| JP7716993B2 (ja) | Ｊａｋキナーゼのピラゾロピリミジンアリールエーテル阻害剤及びその使用 | |
| JP2023520647A5 (enExample) | ||
| CN1910190A (zh) | 环氨基取代的噻吩并嘧啶和噻吩并吡啶衍生物 | |
| CN117957227A (zh) | 作为GABA A γ1 PAM的吡啶并二氮杂䓬衍生物 | |
| RU2854674C1 (ru) | Бензодиазепиновые производные как пам гамк а гамма 1 | |
| HK40103678A (en) | New benzodiazepine derivatives as gaba a gamma1 pam |